Detalhe da pesquisa
1.
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.
Cell
; 182(6): 1401-1418.e18, 2020 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32810439
2.
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19.
Blood
; 136(20): 2290-2295, 2020 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32959052
3.
Paclitaxel with or without pazopanib for ovarian cancer relapsing during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study.
Gynecol Oncol
; 166(3): 389-396, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35902297
4.
Evaluation of supportive care needs, sexuality and quality of life in phase 1 trials: a prospective monocentric study.
Support Care Cancer
; 30(12): 9841-9849, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36271944
5.
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
Lancet Oncol
; 22(12): 1669-1680, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34741822
6.
Impact of young age on platinum response in women with epithelial ovarian cancer: Results of a large single-institution registry.
Gynecol Oncol
; 160(1): 77-82, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33059915
7.
Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes.
Br J Cancer
; 120(9): 913-921, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30899086
8.
Secondary haemophagocytic lymphohistiocytosis is a rare occurrence amongst cancer patients with COVID-19.
Br J Haematol
; 192(3): e87-e90, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33326597
9.
Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry.
Ther Adv Med Oncol
; 16: 17588359231225028, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38249336
10.
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry.
Int J Infect Dis
; 139: 13-20, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38029831
11.
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial.
BMJ Med
; 2(1): e000427, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37920150
12.
Validation of the geriatric vulnerability score in older patients with ovarian cancer: an analysis from the GCIG-ENGOT-GINECO EWOC-1 study.
Lancet Healthy Longev
; 3(3): e176-e185, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36098291
13.
Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients.
EBioMedicine
; 80: 104077, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35644124
14.
Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry.
JAMA Oncol
; 8(1): 114-122, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34817562
15.
The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals.
Cancer Discov
; 12(4): 958-983, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35179201
16.
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry.
J Natl Cancer Inst
; 114(7): 979-987, 2022 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35417006
17.
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries.
J Immunother Cancer
; 10(11)2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36450384
18.
Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.
Cell Death Dis
; 12(3): 258, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33707411
19.
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study.
Eur J Cancer
; 150: 190-202, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33932726
20.
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.
Cell Death Differ
; 28(12): 3297-3315, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34230615